Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

469
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
469
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

166
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
166
Drug Dependence01:17

Drug Dependence

1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Principles of Drug Action01:24

Principles of Drug Action

6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
Drug Therapy01:28

Drug Therapy

43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
43

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identity-Based Behavioral Economic Incentives Increased PrEP Adherence for Transgender and Nonbinary Adults in a Trans-Led PrEP Navigation Program.

AIDS and behavior·2026
Same author

What is Collaborative Care? Reexamining the Principles of Collaborative Care Through Scaling to Complex Populations and Settings.

Journal of general internal medicine·2026
Same author

Reimbursement Potential of Collaborative Care Model (CoCM) Billing Codes for Opioid Use Disorder Co-Occurring with Mental Disorders: Descriptive Estimates from a Pragmatic Trial.

Administration and policy in mental health·2026
Same author

When Billing Codes Fall Short: Unbillable Time in Collaborative Care for Co-occurring Opioid Use and Mental Health Conditions.

Psychiatric services (Washington, D.C.)·2026
Same author

Policy actors' perspectives on improving federal grants to promote the implementation success of evidence-based behavioral health practices.

Implementation science communications·2026
Same author

Substance Use Screening in Pediatric Emergency Departments for Youth in Behavioral Crisis.

JAMA pediatrics·2026

Related Experiment Video

Updated: Jun 29, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.2K

Narrative Review: Revised Principles and Practice Recommendations for Adolescent Substance Use Treatment and Policy.

Justine W Welsh1, Alex R Dopp2, Rebecca M Durham1

  • 1Emory University, Atlanta, Georgia.

Journal of the American Academy of Child and Adolescent Psychiatry
|March 27, 2024
PubMed
Summary

Updated principles for adolescent substance use disorder (SUD) treatment emphasize integrated care, improved accessibility, and harm reduction. These evidence-based practices aim to enhance care standards for adolescents with SUDs.

Keywords:
addictionadolescentspharmacologypublic policysubstance use disorders

More Related Videos

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.0K
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

896

Related Experiment Videos

Last Updated: Jun 29, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.2K
Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.0K
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

896

Area of Science:

  • Addiction Medicine
  • Adolescent Psychiatry
  • Public Health

Background:

  • Established principles for adolescent substance use disorder (SUD) treatment were updated in 2018 to be developmentally appropriate.
  • This review builds upon prior work to recommend updated assessment, treatment, and aftercare principles and practices for adolescent SUDs.

Purpose of the Study:

  • To review and update evidence-based principles and practices for adolescent substance use disorder assessment, treatment, and aftercare.
  • To identify implications for public policy, funding, and future research in adolescent SUD services.

Main Methods:

  • Searched Cochrane, MEDLINE-PubMed, and PsychInfo databases for studies on adolescent substance use services.
  • Updated 13 original principles and condensed 8 modalities into 5 practices.
  • Highlighted implications for policy, funding, and research.

Main Results:

  • Key recommendations include integrating co-occurring mental health and SUD care, improving access via educational systems, and enhancing engagement.
  • Updated practices involve adopting Screening, Brief Intervention and Referral to Treatment (SBIRT), investing in social programs, and expanding behavioral therapies.
  • Emphasized increased funding for harm reduction, support for continuing care, and greater investment in research.

Conclusions:

  • Revised principles provide guidance for evidence-based adolescent SUD assessment, treatment, and aftercare.
  • Encourages policymakers and funding agencies to support improved standards of care for adolescent SUD services.
  • Identified areas for further research and policy changes to enhance adolescent SUD treatment outcomes.